Biogen completes enrolment in STAR trial of timrepigene emparvovec

Choroideremia is a genetic disorder that affects patients’ night vision and could progress to blindness. Credit: Marc Schulte on Unsplash.



  • Biogen completes enrolment in STAR trial of timrepigene emparvovec